<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id><journal-id journal-id-type="pmc">eid</journal-id><journal-title>Emerging Infectious Diseases</journal-title><issn pub-type="ppub">1080-6040</issn><issn pub-type="epub">1080-6059</issn><publisher><publisher-name>Centers for Disease Control</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">10603221</article-id><article-id pub-id-type="pmc">2640808</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Effectiveness of pneumococcal polysaccharide vaccine for preschool-age children with chronic disease.</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Fiore</surname><given-names>A. E.</given-names></name><email>abf4@cdc.gov</email></contrib><contrib contrib-type="author"><name><surname>Levine</surname><given-names>O. S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Elliott</surname><given-names>J. A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Facklam</surname><given-names>R. R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Butler</surname><given-names>J. C.</given-names></name></contrib></contrib-group><aff>Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.</aff><pub-date pub-type="ppub"><season>Nov-Dec</season><year>1999</year></pub-date><volume>5</volume><issue>6</issue><fpage>828</fpage><lpage>831</lpage><abstract><p>To estimate the effectiveness of pneumococcal polysaccharide vaccine, we serotyped isolates submitted to the Pneumococcal Sentinel Surveillance System from 1984 to 1996 from 48 vaccinated and 125 unvaccinated children 2 to 5 years of age. Effectiveness against invasive disease caused by serotypes included in the vaccine was 63%. Effectiveness against serotypes in the polysaccharide vaccine but not in a proposed seven-valent protein conjugate vaccine was 94%.</p></abstract></article-meta></front></article>